FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Dubé

Research Profile

Disorders

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Samir K Gupta; Raymond M Johnson; Matthias A Clauss; Zeruesenay Desta; Michael P Dubé; Kieren J Mather; Deming Mi; Chandan K Saha; James H Stein; Ziyue Liu
Pentoxifylline, inflammation, and endothelial function in HIV-infected persons: a randomized, placebo-controlled trial.
Samir K Gupta; Lisa M Kamendulis; Sharon M Moe; Changyu Shen; Mitchell Goldman; Michael P Dubé
Worsening endothelial function with efavirenz compared to protease inhibitors: a 12-month prospective study.
Emily Blodget; Grace Aldrovandi; Samir K Gupta; Adrienne Rollie; Changyu Shen; James H Stein; Michael P Dubé
Relationship between microbial translocation and endothelial function in HIV infected patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Dubé (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Samir K Gupta; Raymond M Johnson; Matthias A Clauss; Zeruesenay Desta; Michael P Dubé; Kieren J Mather; Deming Mi; Chandan K Saha; James H Stein; Ziyue Liu
Pentoxifylline, inflammation, and endothelial function in HIV-infected persons: a randomized, placebo-controlled trial.
PloS one 2013;8(4):e60852.
2012: Samir K Gupta; Lisa M Kamendulis; Sharon M Moe; Changyu Shen; Mitchell Goldman; Michael P Dubé
Worsening endothelial function with efavirenz compared to protease inhibitors: a 12-month prospective study.
PloS one 2012;7(9):e45716.
2012: Emily Blodget; Grace Aldrovandi; Samir K Gupta; Adrienne Rollie; Changyu Shen; James H Stein; Michael P Dubé
Relationship between microbial translocation and endothelial function in HIV infected patients.
PloS one 2012;7(8):e42624.
2011: Michael P Dubé; Joseph J Cadden
Lipid metabolism in treated HIV Infection.
Best practice & research. Clinical endocrinology & metabolism 2011;25(3):429-42.
2010: Samir K Gupta; Raymond M Johnson; Kieren J Mather; Matthias Clauss; Jalees Rehman; Chandan Saha; Zeruesenay Desta; Michael P Dubé
Anti-inflammatory treatment with pentoxifylline improves HIV-related endothelial dysfunction: a pilot study.
AIDS (London, England) 2010;24(9):1377-80.
2008: Michael P Dubé; Changyu Shen; Martha Greenwald; Kieren J Mather
No impairment of endothelial function or insulin sensitivity with 4 weeks of the HIV protease inhibitors atazanavir or lopinavir-ritonavir in healthy subjects without HIV infection: a placebo-controlled trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(4):567-74.
2008: Francesca J Torriani; Lauren Komarow; Robert A Parker; Bruno Cotter; Judith S Currier; Michael P Dubé; Carl J Fichtenbaum; Mariana Gerschenson; Carol K C Mitchell; Robert L Murphy; Kathleen Squires; James H Stein
Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.
Journal of the American College of Cardiology 2008;52(7):569-76.
2008: Michael P Dubé; Gorski Jan; Changyu Shen
Severe impairment of endothelial function with the HIV-1 protease inhibitor indinavir is not mediated by insulin resistance in healthy subjects.
Cardiovascular toxicology 2008;8(1):15-22.
2007: Michael P Dubé; Lauren Komarow; Kathleen Mulligan; Steven K Grinspoon; Robert A Parker; Gregory Robbins; Ronenn Roubenoff; Pablo Tebas
Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384.
Journal of acquired immune deficiency syndromes (1999) 2007;45(5):508-14.
2007: Michael P Dubé; Robert A Parker; Kathleen Mulligan; Pablo Tebas; Gregory Robbins; Ronenn Roubenoff; Steven K Grinspoon
Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(1):120-6.
2006: Kathleen Mulligan; Robert A Parker; Lauren Komarow; Steven K Grinspoon; Pablo Tebas; Gregory Robbins; Ronenn Roubenoff; Michael P Dubé
Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial.
Journal of acquired immune deficiency syndromes (1999) 2006;41(5):590-7.
2006: Michael P Dubé; Julia W Wu; Judith A Aberg; Mark A Deeg; Beverly Alston-Smith; Mark E McGovern; Daniel Lee; Sharon L Shriver; Ana I Martinez; Martha Greenwald; James H Stein
Safety and efficacy of extended-release niacin for the treatment of dyslipidaemia in patients with HIV infection: AIDS Clinical Trials Group Study A5148.
Antiviral therapy 2006;11(8):1081-9.
2005: Michael P Dubé; Robert A Parker; Pablo Tebas; Steven K Grinspoon; Robert Zackin; Gregory Robbins; Ronenn Roubenoff; Robert W Shafer; David A Wininger; William A Meyer; Snyder Sally; Kathleen Mulligan
Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides.
AIDS (London, England) 2005;19(16):1807-18.
2005: Sudha S Shankar; Michael P Dubé; Gorski Jan; James Klaunig; Helmut O Steinberg
Indinavir impairs endothelial function in healthy HIV-negative men.
American heart journal 2005;150(5):933.
2005: Samir K Gupta; Robert A Parker; Gregory Robbins; Michael P Dubé
The effects of highly active antiretroviral therapy on albuminuria in HIV-infected persons: results from a randomized trial.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(10):2237-42.
2005: Michael P Dubé; Douglas W Kitch; Robert A Parker; Beverly Alston-Smith; Kathleen Mulligan
The effect of long-term storage on measured plasma lactate concentrations and prospective lactate results from a multicenter trial of antiretroviral therapy.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2005;43(9):947-52.
2004: Sudha S Shankar; Michael P Dubé
Clinical aspects of endothelial dysfunction associated with human immunodeficiency virus infection and antiretroviral agents.
Cardiovascular toxicology 2004;4(3):261-9.
2004: Erika M Young; Robert V Considine; Fred R Sattler; Mark A Deeg; Thomas A Buchanan; Mikako Degawa-Yamauchi; Sudha Shankar; Hannah Edmondson-Melançon; Jaime Hernandez; Michael P Dubé
Changes in thrombolytic and inflammatory markers after initiation of indinavir- or amprenavir-based antiretroviral therapy.
Cardiovascular toxicology 2004;4(2):179-86.
2003: Gregory Robbins; Victor De Gruttola; Robert W Shafer; Laura M Smeaton; Snyder Sally; Carla Pettinelli; Michael P Dubé; Margaret A Fischl; Richard B Pollard; Robert Delapenha; Linda Gedeon; Charles van der Horst; Robert L Murphy; Mark I Becker; Richard T D'Aquila; STEFANO VELLA; Thomas C Merigan; Martin S Hirsch
Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection.
The New England journal of medicine 2003;349(24):2293-303.
2003: Michael P Dubé; James H Stein; Judith A Aberg; Carl J Fichtenbaum; John G Gerber; Karen T Tashima; W Keith Henry; Judith S Currier; Dennis Sprecher; Marshall J Glesby
Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(5):613-27.
2002: Morris Schambelan; Constance A Benson; Andrew Carr; Judith S Currier; Michael P Dubé; John G Gerber; Steven K Grinspoon; Carl Grunfeld; Donald P Kotler; Kathleen Mulligan; William G Powderly; Michael S Saag
Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.
Journal of acquired immune deficiency syndromes (1999) 2002;31(3):257-75.
2002: Samir K Gupta; Michael P Dubé
Exogenous cushing syndrome mimicking human immunodeficiency virus lipodystrophy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(6):E69-71.
2002: Michael P Dubé; Dajun Qian; Hannah Edmondson-Melançon; Fred R Sattler; Diane Goodwin; Carmen Martinez; Vanessa Williams; Debra Johnson; Thomas A Buchanan
Prospective, intensive study of metabolic changes associated with 48 weeks of amprenavir-based antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(4):475-81.
2001: Richard Haubrich; Judith S Currier; Donald N Forthal; Gildon N Beall; Carol A Kemper; D Johnson; Michael P Dubé; J Hwang; John Leedom; Jeremiah G Tilles; J Allen McCutchan
A randomized study of the utility of human immunodeficiency virus RNA measurement for the management of antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(7):1060-8.
2001: Michael P Dubé; Hannah Edmondson-Melançon; Dajun Qian; R Aqeel; Debra Johnson; Thomas A Buchanan
Prospective evaluation of the effect of initiating indinavir-based therapy on insulin sensitivity and B-cell function in HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2001;27(2):130-4.
2001: Carol A Kemper; Mallory D Witt; Philip H Keiser; Michael P Dubé; Donald N Forthal; Matthew Leibowitz; D S Smith; A Rigby; Nicholas S Hellmann; Yolanda Lie; John Leedom; Douglas Richman; J Allen McCutchan; Richard Haubrich
Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors.
AIDS (London, England) 2001;15(5):609-15.
2000: Michael P Dubé
Disorders of glucose metabolism in patients infected with human immunodeficiency virus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;31(6):1467-75.
2000: Michael P Dubé; Dennis Sprecher; W Keith Henry; Judith A Aberg; Francesca J Torriani; H N Hodis; J Schouten; J Levin; G Myers; Robert Zackin; T Nevin; Judith S Currier
Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;31(5):1216-24.
1999: MW Dunne; Samuel A Bozzette; J Allen McCutchan; Michael P Dubé; Fred R Sattler; Donald N Forthal; Carol A Kemper; Diane V Havlir
Efficacy of azithromycin in prevention of Pneumocystis carinii pneumonia: a randomised trial. California Collaborative Treatment Group.
Lancet 1999;354(9182):891-5.
1999: Richard Haubrich; S J Little; Judith S Currier; Donald N Forthal; Carol A Kemper; Gildon N Beall; D Johnson; Michael P Dubé; J Y Hwang; J Allen McCutchan
The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group.
AIDS (London, England) 1999;13(9):1099-107.
1999: Robert T Koda; Michael P Dubé; Wen Yen Li; D J Chatterjee; J D Stansell; Fred R Sattler
Pharmacokinetics of trimetrexate and dapsone in AIDS patients with Pneumocystis carinii pneumonia.
Journal of clinical pharmacology 1999;39(3):268-74.
1999: Michael P Dubé; Francesca J Torriani; DM See; Diane V Havlir; Carol A Kemper; John Leedom; Jeremiah G Tilles; J Allen McCutchan; Fred R Sattler
Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(1):136-8.
1998: Diane V Havlir; Michael P Dubé; J Allen McCutchan; Donald N Forthal; Carol A Kemper; MW Dunne; D M Parenti; P N Kumar; A C White; Mallory D Witt; S D Nightingale; Kent A Sepkowitz; Rob Roy MacGregor; S H Cheeseman; Francesca J Torriani; M T Zelasky; Fred R Sattler; Samuel A Bozzette
Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(6):1369-75.
1997: Michael P Dubé; Fred R Sattler; Francesca J Torriani; DM See; Diane V Havlir; Carol A Kemper; M G Dezfuli; Samuel A Bozzette; A E Bartok; John Leedom; Jeremiah G Tilles; J Allen McCutchan
A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycin-based combination therapy. California Collaborative Treatment Group.
The Journal of infectious diseases 1997;176(5):1225-32.
1997: Michael P Dubé; D L Johnson; J S Currier; John Leedom
Protease inhibitor-associated hyperglycaemia.
Lancet 1997;350(9079):713-4.
1997: Michael P Dubé; P N Heseltine; M G Rinaldi
Nystatin prophylaxis.
Clinical microbiology reviews 1997;10(2):368.
1997: S Sarkar; Michael P Dubé; B E Jones; Fred R Sattler
Pneumocystis carinii pneumonia masquerading as tuberculosis.
Archives of internal medicine 1997;157(3):351-5.
1996: Diane V Havlir; Michael P Dubé; Fred R Sattler; Donald N Forthal; Carol A Kemper; MW Dunne; D M Parenti; J P Lavelle; A C White; M D Witt; Samuel A Bozzette; J Allen McCutchan
Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
The New England journal of medicine 1996;335(6):392-8.
1996: Michael P Dubé; Fred R Sattler
Catheter-related bacteremia due to Mycobacterium avium complex.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(2):405-6.
1994: Diane V Havlir; Francesca J Torriani; Michael P Dubé
Uveitis associated with rifabutin prophylaxis.
Annals of internal medicine 1994;121(7):510-2.
1994: Carol A Kemper; Diane V Havlir; D Haghighat; Michael P Dubé; A E Bartok; J P Sison; Y Yao; B Yangco; John Leedom; Jeremiah G Tilles
The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS.
The Journal of infectious diseases 1994;170(1):157-64.
1994: Michael P Dubé; P N Heseltine; M G Rinaldi; S Evans; B Zawacki
Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;18(1):77-82.
1993: Michael P Dubé; Fred R Sattler
How useful are cytomegalovirus cultures in patients with HIV infection?
Annals of internal medicine 1993;119(3):248.
1992: Michael P Dubé; Paul D Holtom; Robert A Larsen
Tuberculous meningitis in patients with and without human immunodeficiency virus infection.
The American journal of medicine 1992;93(5):520-4.